Follow on Google News News By Tag * Food * Drug * Vitamins * ACT * Pharmaceutical * Patent * Department * Legislative * Property * Dollar * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | New Market Research Report: Taiwan Pharmaceuticals & Healthcare Report Q1 2011Fast Market Research recommends "Taiwan Pharmaceuticals & Healthcare Report Q1 2011" from Business Monitor International, now available
Taiwan's Pharmaceuticals & Healthcare Business Environment Ratings score increased from 58.0 in Q410 to 58.7 in Q111. However, the country's regional ranking fell from sixth to seventh, as a result of Hong Kong's score increasing from 57.0 to 60.1. Taiwan scores above the regional average score for 'Country Rewards', Industry Risks' and Country Risks'. The country matches the regional average score for 'Industry Rewards'. Over the medium term, we expect Taiwan to fall further down the proprietary ranking system. Demonstrating the reactivity of the Department of Health, pharmaceutical firms were instructed on October 09 2010 to recall slimming capsules containing sibutramine, which is the active ingredient in Abbott Laboratories' Meridia. This was just one day after the US Food and Drug Administration (FDA) announced that Abbott had agreed to voluntarily withdraw the oral anorexiant from the US market. Taiwan's intellectual property regime is below international standards. In August 2010, Taiwan's Legislative Yuan was looking to incorporate extensive changes to the country's Patent Act. The Taiwan Intellectual Property Office (TIPO) has conducted a number of public hearings since 2006 to modify the Patent Act, which was last amended in 2003. The TIPO submitted the draft act to the Legislative Yuan for review on December 11 2009. The draft has been prepared with the aim of enhancing Taiwan's economic and industrial competitiveness, promoting the development of biotechnology and other important technology as well as strengthening the patent examination process. The US$319mn OTC medicines sector is facing downward pressure but is expected to post a 3.71% CAGR over the next five years. It was announced in September 2010 that all low-strength vitamins - including vitamins A, B, C, D, E, K, nicotinic acid and folic acid - are to be sold as food products rather than drug products in Taiwan from 2011. Under the new policy, vitamins will be available in supermarkets and convenient stores. Vitamins still in the drug category will have to secure new licences, while those in the food category are required to register with the Department of Health before April 2012. According to an official from the Taiwanese Food and Drug Administration, Wang Hui-Ing, nearly 500 out of 600 low-strength vitamin products need to modify their licences under the new policy. For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: Executive Summary SWOT Analysis - Taiwan Pharmaceuticals And Healthcare Industry SWOT - Taiwan Political SWOT - Taiwan Economic SWOT - Taiwan Business Environment SWOT Pharmaceutical Business Environment Ratings - Table: Asia Pacific - Regional Pharmaceutical Business Environment Ratings For Q111 - Rewards - Risks Taiwan - Market Summary Regulatory Regime - Table: Examples Of Controlled Drugs In Taiwan - Table: Medicine Categories In Taiwan - Recent Regulatory Developments - Intellectual Property Regime - Intellectual Property Developments - Compulsory Licensing - Counterfeits - Pricing Regime - Price Cuts - Reimbursement Regime - Taiwan: Medical Costs Claimed - Taiwan: Insurance Coverage - Table: Drug Reimbursement Principles - Free Trade Agreements Industry Developments - Epidemiology - Non-Communicable Diseases - Communicable Diseases - Healthcare Insurance - Healthcare Financing - Table: Medical Care Institution Contracting And Management Of Taiwan's National Healthcare Insurance Fund (NHIF) For 2007 - Table: Statistics of Taiwan's National Healthcare Insurance Fund (NHIF) for 2007 - Table: Premium Contribution For Taiwan's Bureau Of National Health Insurance (% share) - Recent Healthcare System Developments - Traditional Chinese Medicine - Biotechnology Sector - Recent Biotechnology Developments - Clinical Trials - Medical Tourism - Vaccines - Recent Developments In The Vaccines Market - Medical Devices Industry Forecast Scenario - Overall Market Forecast - Table: Pharmaceutical Sales Indicators 2006-2014 - Key Growth Factors - Industry - Table: Health Expenditure Indicators 2006-2014 - Table: Government Health Expenditure Indicators 2006-2014 - Table: Private Health Expenditure Indicators 2006-2014 - Key Growth Factors - Macroeconomic - Table: Taiwan - Economic Activity - Prescription Drug Market Forecast - Table: Prescription Drug Sales Indicators 2006-2014 - Patented Drug Market Forecast - Table: Patented Drug Sales Indicators 2006-2014 - Generic Drug Market Forecast - Table: Generic Drug Sales Indicators 2006-2014 - OTC Medicine Market Forecast - Full Table of Contents is available at: -- http://www.fastmr.com/ About Business Monitor International Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number